Answer below questions. 1: (a) Briefly explain the function and the mechanism of action of proprotein convertase subtilisin/Kexin type 9
Answer below questions. 1: (a) Briefly explain the function and the mechanism of action of proprotein convertase subtilisin/Kexin type 9 (PCSK9) and explain how it was initially identified in humans as an attractive target or dyslipidemia drug development. With diagram. (b) Describe in detail a pre- clinical strategy for…